The Affordable Care Act (ACA) required most insurers and the Medicare program to eliminate cost sharing for screening mammography.
Elimination of Cost Sharing for Screening Mammogr aphy
A n extensive body of evidence, including a landmark clinical trial, has shown that cost sharing -requiring people to pay for health care in the form of a deductible, copayment, or other out-of-pocket expense -reduces the use of health services. [1] [2] [3] [4] Cost sharing deters the use of effective, but often underused, preventive health care. [4] [5] [6] [7] On the basis of this evidence, the Affordable Care Act (ACA) required most private insurance plans and the federal Medicare program to eliminate cost sharing for preventive services that are recommended by the U.S. Preventive Services Task Force (USPSTF). 8 The elimination of cost sharing for preventive care was one of the first large-scale applications of value-based insurance design, which links the generosity of insurance coverage for a service to the value of that service in improving health. 9 Out-of-pocket payments for preventive services disproportionately affect women. As compared with men, women have higher out-of-pocket spending on health care and are more likely to delay or avoid recommended preventive care because of costs. 10 Of the 44 preventive services recommended by the USPSTF for adults, 26 apply specifically to women, and none apply specifically to men. 11 A requirement for even modest copayments for woman-specific preventive services, such as mammograms or Papanicolaou smears, reduces the number of women who receive this care. 6, 7, 12 The negative effects of copayments are larger for mammography than for other preventive services and are more pronounced among women of lower socioeconomic status. 7, 12 Breast cancer is the second leading cause of cancer-related death among women and most commonly occurs among older women. 13 Because age-appropriate screening can reduce mortality from breast cancer, the USPSTF recommends biennial screening for women 50 to 74 years of age who are at average risk for breast cancer and has concluded that "women aged 60 to 69 years are most likely to avoid breast cancer death through mammography screening." 14 This study of Medicare Advantage plans, which enrolled 31% of the Medicare population in 2016, 15 addressed two main questions. First, does the elimination of cost sharing increase rates of screening mammography among older women? Second, do the effects of eliminating cost sharing vary according to race, ethnic group, and socioeconomic status?
Me thods

Study Design and Data Sources
We conducted a difference-in-differences study to compare rates of biennial screening mammography in Medicare Advantage plans that eliminated cost sharing for this service against matched control plans that had and maintained full coverage. We obtained the Healthcare Effectiveness Data and Information Set (HEDIS) from 2007 through 2013 for Medicare Advantage plans and linked these data to the Medicare Beneficiary Summary File and information on the benefits of the health plans. The match rate between the HEDIS and the Medicare Beneficiary Summary File was 99.6%. To obtain data on area-level socioeconomic status, we linked enrollees' ZIP Codes to 2010 Census data. The study protocol was approved by the Brown University Human Research Protections Office and the Centers for Medicare and Medicaid Services Privacy Board.
Identifying Intervention and Control Plans
Among plans with at least 4 years of continuous participation in the Medicare Advantage program from 2007 through 2013, we identified 24 plans that required cost sharing for screening mammography for at least 2 years before its elimination. These plans are hereafter referred to as "intervention plans." We defined cost sharing as a requirement for an out-of-pocket payment (i.e., copayment or coinsurance) for screening mammography. Because the health reform legislation was passed in the Senate in 2009 and by the House of Representatives in 2010 and was officially signed into law in 2010, we included plans that eliminated cost sharing in 2009 (17 plans), 2010 (4 plans), and 2011 (3 plans).
We identified 239 potential control plans that provided full coverage of mammography before and after the ACA mandate and operated in the same state as the intervention plans or in a bordering state. We randomly ordered the 24 intervention plans and matched each of them to 2 randomly chosen control plans that operated in the same state. For 4 intervention plans, we could not identify 2 control plans in the same state; in those cases, we instead selected one or both controls from a bordering state. We matched plans without replacement, which yielded 24 intervention plans and 48 matched control plans.
T h e ne w e ngl a nd jou r na l o f m e dicine
We matched plans without awareness of information on mammography utilization.
Study Population
Our study population included women 65 years of age or older who were eligible for the HEDIS quality measure for breast-cancer screening. The measure required women to have been enrolled in the Medicare Advantage plan for 2 years with no gap in coverage exceeding 45 days. Before 2012, the upper age limit for the HEDIS indicator was 69 years; from 2012 onward, the upper age limit was 74 years. We excluded women who were dually eligible for Medicare and Medicaid coverage.
Outcomes and Covariates
The outcome variable was a dichotomous variable (yes or no) indicating whether at least one screening mammogram had been received in a given calendar year or the year before (i.e., biennial screening). Women could contribute more than one observation if they were sampled for the HEDIS indicator in different calendar years. Our primary independent variable was the product term of enrollment in an intervention plan and time period (before or after the elimination of cost sharing). Because our outcome was biennial screening, we restricted the post-policy observations to those that occurred during the second full calendar year after the elimination of cost sharing, in order to capture a period during which all screening mammograms were free.
We obtained information on the following covariates: age (in years), race and ethnic group (based on a validated algorithm 16 ), the proportion of persons 65 years of age or older living in the enrollee's ZIP Code who completed high school, the proportion of persons 65 years of age or older living below the federal poverty level in the enrollee's ZIP Code, and calendar year. We assigned women to quartiles of ZIP Code-level poverty and ZIP Code-level educational attainment, using our study cohort to determine quartile cutoff points. We did not include plan-level covariates because they did not vary over time.
Statistical Analysis
We estimated treatment effects with generalized linear models in which receipt of biennial screening was the outcome, using a binomial distribution and the identity link function. We adjusted treatment effects for the covariates described above and obtained standard errors that accounted for clustering of observations at the level of the health plan. 17 We excluded from our regression analyses 1406 women (1.8%) for whom ZIP Code-level socioeconomic data were missing. Our main analyses included data from the calendar year before cost sharing was eliminated and from the second full calendar year after the copayment was eliminated. Sensitivity analyses included all observations from plans up to 2 years before and 3 years after cost sharing was removed. To examine changes in the rates of biennial mammography that occurred before the elimination of cost sharing, we graphed screening rates in intervention and control plans over time and tested an interaction between intervention and time, using data from the period before the elimination of cost sharing. Further information about the regression specification and additional sensitivity analyses is provided in the Supplementary Appendix, available with the full text of this article at NEJM.org.
We examined whether effects varied across the 24 matched groups of intervention and control plans. We also examined effect modification according to race and ethnic group, quartile of ZIP Code-level poverty, and quartile of ZIP Codelevel educational attainment, using three-way product terms ("interactions") between intervention status, time, and the effect modifiers. Analyses were conducted with SAS software, version 9.4 (SAS Institute).
R esult s
Characteristics of the Study Population
The study population included 16,202 observations from 15,085 women in intervention plans and 61,164 observations from 52,035 women in control plans. Of the 48 control plans, 43 were located in the same state as the matched intervention plan; the remaining 5 were in a bordering state. As compared with women in control plans, women in intervention plans were significantly younger, less likely to be a member of a racial or ethnic minority group, and more likely to be living in areas with lower rates of highschool completion and higher rates of poverty (P<0.001); the magnitudes of these differences were modest (Table 1) . Table S1 in the Supplementary Appendix provides additional descrip-Elimination of Cost Sharing for Screening Mammogr aphy tion of the included plans. Of the 24 intervention plans, 2 eliminated coinsurance of 20%, and the remaining 22 eliminated copayments of either $25 or $30.
Changes in Rates of Biennial Screening Mammography
In intervention plans, rates of biennial screening mammography increased from 59.9% (95% confidence interval [CI] , 54.9 to 65.0) in the 2-year period before cost sharing was eliminated to 65.4% (95% CI, 61.8 to 69.0) in the 2-year period after cost sharing was eliminated ( Table 2) . In control plans, the rates of biennial screening were 73.1% (95% CI, 69.2 to 77.0) in the prepolicy period and 72.8% (95% CI, 69.7 to 76.0) in the postpolicy period. The adjusted difference in differences between the intervention and control plans was 5.7 percentage points (95% CI, 3.0 to 8.4). In analyses stratified according to the year of cost-sharing elimination, we found adjusted difference-in-differences estimates of 5.4 percentage points (95% CI, 2.3 to 8. 
percentage points (95% CI, −3.7 to 15.4) for the 3 plans that eliminated cost sharing in 2011.
Trends in adjusted screening rates throughout the study period are shown in Figure 1 , and Figure S1 in the Supplementary Appendix shows trends in adjusted difference-in-differences estimates for the intervention and control plans. Relative to concurrent screening rates in control plans, screening rates in intervention plans declined significantly during the 2 years before cost-sharing elimination and then increased significantly after cost-sharing elimination. The difference-in-differences estimates were not significant thereafter. Figure 2 shows adjusted difference-in-differences estimates in each of the 24 groups of intervention and control plans. The median difference-in-differences estimate was 6.0 percentage points (interquartile range, 0.0 to 9.2). For 18 of the 24 groups, the difference-in-differences estimate was positive, indicating an increase in the rate of screening in the intervention plan as compared with the rates in matched control plans.
Our findings were stable in sensitivity analyses (Table S2 in the Supplementary Appendix) that used different model specifications, excluded women contributing multiple observations to the analyses, excluded matched groups with extreme results, restricted the analysis to for-profit plans, treated socioeconomic covariates as categorical terms, and used alternative approaches for handling missing socioeconomic data. Table 3 shows the difference-in-differences estimates for screening rates in intervention plans as compared with those in control plans according to race, ethnic group, and area-level socio- Shown are point estimates and corresponding 95% confidence intervals for adjusted difference-in-differences estimates (arranged in ascending order) comparing each intervention plan with the two matched control plans in the 2-year period before and the 2-year period after the elimination of cost sharing. Values greater than zero (above the dashed line) indicate increases in screening mammography rates for the intervention plan as compared with the matched control plans. 
Changes in Rates According to Race or Ethnic Group, Education, and Socioeconomic Status
Matched Group
Elimination of Cost Sharing for Screening Mammogr aphy economic status. ; P = 0.24 for interaction). As indicated by the difference-in-differences estimates, the elimination of cost sharing led to increases of 6.5 percentage points (95% CI, 3.7 to 9.4) and 8.4 percentage points (95% CI, 2.5 to 14.4) among white and black women, respectively, but almost no change among Hispanic women (difference-in-differences estimate, 0.4 percentage points; 95% CI, −7.3 to 8.1), although the differential effect according to race and ethnic group was not significant (P = 0.18 for interaction).
Discussion
This study of the effects of eliminating cost sharing for screening mammography has three main findings. First, among Medicare Advantage plans that eliminated cost sharing, rates of screening mammography increased by approximately 6 percentage points as compared with matched control plans that maintained full coverage for mammography. Second, the increases in screening occurred during the immediate 2-year period after cost sharing was eliminated, with little increase after that time. Third, cost sharing elimination appeared to have attenuated effects among women living in areas with lower educational attainment and negligible effects among Hispanic women. Our findings extend those of previous studies showing that, among older women, receipt of screening mammography is sensitive to out-ofpocket costs and the presence of supplemental coverage. For instance, we previously reported that copayments of approximately $20 were associated with reductions in rates of breast-cancer screening of 8 to 11 percentage points. 7 Another study reported that female Medicare beneficiaries with supplemental insurance coverage were twice as likely as women who lacked supplemental coverage to receive mammography in the first 2 years that Medicare began covering this service. 18 The absolute magnitude of these reductions was larger than the increases in mammography rates observed in our study after the elimination of copayments. The difference in magnitude is consistent with economic theory suggesting that removal of cost sharing for health services will generally have a smaller (absolute) effect than the imposition of cost sharing of the same value. 19 Several before-and-after studies have shown minimal changes in the rates of use of mammography and other preventive services after the implementation of the ACA. [20] [21] [22] [23] [24] These studies examined population trends without specifically identifying groups that were relieved of costsharing requirements. Two quasi-experimental T h e ne w e ngl a nd jou r na l o f m e dicine studies, each using data from a single insurer, have reported mixed findings. The first study did not detect increases in the use of diagnostic and screening mammography in the first 9 months after the implementation of the ACA among Humana beneficiaries. 25 The second study reported smaller declines in rates of screening mammography among Medicare Advantage enrollees in Kaiser Northern California who had copayments removed than among enrollees with continuously free mammography. 26 Our study extends this research by applying a quasi-experimental design to a national sample of 72 Medicare Advantage plans.
Our finding that women living in areas of lower educational attainment were less responsive to the cost-sharing reduction may seem counterintuitive. It is consistent, however, with emerging evidence about vulnerable patients' awareness of features of health insurance and the ACA. For instance, a survey from the Kaiser Family Foundation reported that in 2014, just 43% of respondents were aware that the ACA eliminated cost sharing for preventive care. 27 Among persons with income near the poverty level, only 22% reported hearing "some" or "a lot" about the availability of preventive care without copayments or coinsurance. 28 Latino patients have been found to have less awareness of the ACA than the general population. 29 Furthermore, studies within the past 5 years have documented socioeconomic disparities in knowledge of basic concepts of health insurance. [30] [31] [32] [33] An American Life Panel survey reported that approximately 30% of persons with an income at or below the federal poverty limit could correctly describe a deductible. 32 These findings, along with the results of our study, support the importance of outreach to Hispanic women and socioeconomically vulnerable populations about reductions in cost sharing for preventive care and other similar value-based changes in insurance policies. Otherwise, such strategies may paradoxically increase disparities if affluent and better-educated patients are more likely to understand and respond to them.
Our study has additional policy implications. Since screening rates in the plans that eliminated cost sharing remained below those in plans with full coverage and less than three quarters of women in control plans received biennial breastcancer screening, the removal of out-of-pocket payments alone may not raise screening rates to desired levels. Furthermore, our findings must be considered in the context of the potential repeal of the ACA. If the cost-sharing provisions of the ACA are rescinded, our results raise concern that fewer older women will receive recommended breast-cancer screening.
The primary limitation of this study is that women were not randomly assigned to intervention and control plans and plans were not randomly assigned to the policy change. We attempted to mitigate this bias by matching intervention and control plans geographically and by using a difference-in-differences design that controls for time-invariant plan characteristics. Of note, screening rates in intervention plans remained lower than those in control plans even after cost sharing was eliminated. This finding suggests that intervention plans differed from control plans in ways other than coverage of screening mammography. For instance, control plans may have used more effective quality-improvement strategies to raise mammography rates. To account for our findings, however, these efforts or other unobserved differences between intervention and control plans would need to have occurred after the elimination of cost sharing and to have affected the rate of mammography only during the immediate 2-year period when screening mammography first became free.
An additional limitation is the use of ZIP Code-level measures of income and education, which are imperfect proxies for individual-level measures. 34 Our data lacked information to further characterize Hispanic subgroups; rates of mammography vary widely among Hispanic Americans according to area of origin and length of U.S. residency. 35, 36 We could not assess the clinical appropriateness of screening decisions for women with limited life expectancy or screening rates for women at increased risk for breast cancer. Some guidelines recommend more frequent screening or the addition of other modes of screening for women at higher-than-average risk for breast cancer. 37 Finally, our findings may not be generalizable to other preventive services or non-Medicare Advantage plans.
In conclusion, the elimination of cost sharing for screening mammography in Medicare Advantage plans was associated with increased use of this service among older women for whom screening is recommended. The increase was attenuated among women living in areas with lower educational attainment and was negligible among Hispanic women.
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